Ozempic’s approval follows Jardiance’s expanded heart indication last July.
Lamotrigine was contaminated with a heart drug.
Major depression drug recalled over wrong dosage.
Already approved for adult patients, Fiasp is now available for children.
Approval of Ubrelvy follows several new migraine drugs.
Pfizer bucks the trend with as high as 98.5% price cuts.
The fish oil drug is approved to reduce cardiovascular risk.
Diabetes and hypertension are among the primary diseases included.
Alkermes omitted warnings about serious risks from taking the drug.
Stephen Hahn is confirmed by the U.S. Senate.